Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
European Health and Pharmaceutical Law Review is Scopus-indexed (Q4, CiteScore 0.2). Published by Lexxion Verlagsgesellschaft mbH.
Checked against the index lists dated .
ISSN 2751-3971Verify ISSN ↗2751-398XVerify ISSN ↗
Publisher: Lexxion Verlagsgesellschaft mbH
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 51 / 57 | 11th | Q4 |
| Law | 1037 / 1162 | 10th | Q4 |
| Pharmaceutical Science | 175 / 191 | 8th | Q4 |
| Drug Discovery | 159 / 161 | 1st | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2025–present (also 2023), best quartile Q4, CiteScore 0.2.
European Health and Pharmaceutical Law Review is Q4 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 51 of 57), Q4 in Law (rank 1037 of 1162) and Q4 in Pharmaceutical Science (rank 175 of 191), by CiteScore 2025. It is ranked in 4 subject areas in all.
European Health and Pharmaceutical Law Review is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.2, quartile Q4, 11th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.107, quartile Q4, with an H-index of 1.
European Health and Pharmaceutical Law Review is published by Lexxion Verlagsgesellschaft mbH. Its print ISSN is 2751-3971 and its online ISSN is 2751-398X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
European Health and Pharmaceutical Law Review has an h-index of 2 and a 2-year mean of 0.04 citations per paper (OpenAlex). Its Scopus CiteScore is 0.2, quartile Q4. On 2-year citations it ranks #50 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
European Health and Pharmaceutical Law Review published 29 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.